Skip to main content
search
Conference

JSSX 2026 in Japan

Conference: JSSX 2026 in Japan

Date: November 17 - 19, 2026

Location: Tsukuba, Japan

Join Certara at JSSX 2026 in Tsukuba!

We’re excited to participate in JSSX 2026 in Kyoto, The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics. Please feel free to stop by our booth to ask any questions about software and services. Japanese experts will be at Certara’s booth to answer your questions.

Refining dosing strategies and enhancing risk assessment with Simcyp® and PBPK services

Visit Certara’s booth to discover how Simcyp® PBPK modeling and PBPK services accelerate drug development. Our PBPK experts apply gold-standard PBPK technology to predict first-in-human doses, drug-drug interactions, and outcomes in special populations—reducing costly clinical trials. With 120+ FDA-approved drugs supported and adoption by 11 regulatory agencies worldwide, learn why Simcyp is the trusted choice for regulatory-ready biosimulation.​

Where to hear Certara insights and expertise

Coming soon

Request a meeting with our experts


You May Also Like

When to Conduct Hepatic Impairment Studies and When Modeling May be Enough
When to Conduct Hepatic Impairment Studies and When Modeling May be EnoughBlog

When to Conduct Hepatic Impairment Studies and When Modeling May be Enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
ASA Biopharmaceutical Section Regulatory-Industry Statistics WorkshopConference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Integrated mechanistic modeling approaches in oncology drug development
Integrated mechanistic modeling approaches in oncology drug developmentWebinar

Integrated mechanistic modeling approaches in oncology drug development

Fact Sheet

From first-in-human trials to global regulatory approvals and post-launch, Certara solutions can help you move your science forward faster, with confidence.

Download now